Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood–Derived Products Marketed as Stem Cell Therapies

IMPORTANCE: The number of clinics marketing stem cell products for joint diseases, chronic pain, and most recently, COVID-19, has increased despite warnings from the US Food and Drug Administration that stem cell products for these and other indications have not been proven safe or effective. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartnett, Kathleen P., Powell, Krista M., Rankin, Danielle, Gable, Paige, Kim, Janice J., Spoto, Samantha, Breaker, Erin, Hunter, Robert, Dotson, Nychie, McAllister, Gillian, Stevens, Valerie, Halpin, Alison Laufer, Houston, Hollis, Epson, Erin, Malarkey, Mary, Mendoza, Melissa, McNeill, Lorrie, Perkins, Kiran M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498849/
https://www.ncbi.nlm.nih.gov/pubmed/34618037
http://dx.doi.org/10.1001/jamanetworkopen.2021.28615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498849/
https://www.ncbi.nlm.nih.gov/pubmed/34618037
http://dx.doi.org/10.1001/jamanetworkopen.2021.28615

Ejemplares similares